Keri Cavanagh currently serves as the Head of Contracts, Pricing, and Analytics for US Patient Value and Access at Takeda Oncology, a position held since August 2023. Prior to this, Keri held the role of VP, Head of Contracting, Pricing, Forecasting, and Insights for Market Access and Patient Solutions at EMD Serono, Inc. from December 2021 to August 2023, and previously served as Associate Director of Contract Operations within the same company from August 2013 to November 2018. Keri's earlier experience includes a position as Senior Contracts Administrator at Draper Laboratory, where management of approximately $60 million in funded contracts was a key responsibility. Keri holds a Doctor of Law (J.D.) degree from New England Law | Boston and a Bachelor's degree in Health Management and Policy from the University of New Hampshire.